Pacific Biosciences of California Inc (PACB)
1.825
+0.06
(+3.69%)
USD |
NASDAQ |
May 03, 16:00
1.85
+0.02
(+1.37%)
After-Hours: 20:00
Pacific Biosciences of California Cash from Investing (Quarterly): -66.58M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -66.58M |
| September 30, 2023 | 242.32M |
| June 30, 2023 | -98.59M |
| March 31, 2023 | -72.55M |
| December 31, 2022 | 80.40M |
| September 30, 2022 | 53.91M |
| June 30, 2022 | -60.28M |
| March 31, 2022 | 42.05M |
| December 31, 2021 | 65.75M |
| September 30, 2021 | -291.65M |
| June 30, 2021 | -460.81M |
| March 31, 2021 | 8.17M |
| December 31, 2020 | -98.50M |
| September 30, 2020 | -63.64M |
| June 30, 2020 | -2.859M |
| March 31, 2020 | -54.33M |
| December 31, 2019 | -3.408M |
| September 30, 2019 | 19.66M |
| June 30, 2019 | 7.812M |
| March 31, 2019 | 37.98M |
| December 31, 2018 | -5.513M |
| September 30, 2018 | -37.34M |
| June 30, 2018 | 12.19M |
| March 31, 2018 | -7.749M |
| December 31, 2017 | 10.68M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.883M |
| June 30, 2017 | -42.59M |
| March 31, 2017 | 25.48M |
| December 31, 2016 | 6.672M |
| September 30, 2016 | 10.86M |
| June 30, 2016 | -9.16M |
| March 31, 2016 | -23.24M |
| December 31, 2015 | -22.43M |
| September 30, 2015 | 14.57M |
| June 30, 2015 | 1.17M |
| March 31, 2015 | 15.30M |
| December 31, 2014 | -1.509M |
| September 30, 2014 | 12.70M |
| June 30, 2014 | 0.179M |
| March 31, 2014 | 8.198M |
| December 31, 2013 | -24.15M |
| September 30, 2013 | 3.763M |
| June 30, 2013 | -7.145M |
| March 31, 2013 | -5.583M |
| December 31, 2012 | 32.20M |
| September 30, 2012 | 15.90M |
| June 30, 2012 | 0.71M |
| March 31, 2012 | 12.98M |
| December 31, 2011 | 15.80M |
| September 30, 2011 | 23.08M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-460.81M
Minimum
Jun 2021
242.32M
Maximum
Sep 2023
-39.64M
Average
-3.408M
Median
Dec 2019
Cash from Investing (Quarterly) Benchmarks
| AtriCure Inc | 9.644M |
| BioSig Technologies Inc | -0.004M |
| Intellia Therapeutics Inc | 45.94M |
| Shockwave Medical Inc | -242.26M |
| Outset Medical Inc | 23.42M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -57.56M |
| Cash from Financing (Quarterly) | -81.60M |
| Free Cash Flow | -268.02M |
| Free Cash Flow Per Share (Quarterly) | -0.2229 |
| Free Cash Flow to Equity (Quarterly) | -60.32M |
| Free Cash Flow to Firm (Quarterly) | -56.04M |
| Free Cash Flow Yield | -57.91% |